Irinotecan Hcl

Irinotecan Hcl
Product Description

Avra developed an optimal process for the total synthesis of SN-38 and its conversion to Irinotecan Hcl USP and give more purity (Assay) NLT 99%. manufacturing in USFDA approved facility and support regulatory requirements.
USDMF and EDMF available

Read more Show less

Avra Laboratories Pvt. Ltd.

  • IN
  • 2015
    On CPHI since
View company profile
Specifications
  • Supplied from
    India
  • Measured In
    kilogram
More specifications Fewer specifications

Avra Laboratories Pvt. Ltd.

  • IN
  • 2015
    On CPHI since
View company profile

More Products from Avra Laboratories Pvt. Ltd. (2)

  • 10-hydroxycamptothecin

    Product 10-hydroxycamptothecin

    Avra Laboratories is first Company in the world to develop a synthetic route 10-hydroxycamptothecin. manufacturing in USFDA approved facility and support  USDMF for regulatory fillings (key intermediate of Topotecan).

  • 7-Ethyl-10-hydroxycamptothecin (SN-38)

    Product 7-Ethyl-10-hydroxycamptothecin (SN-38)

    Avra Laboratories is first Company in the world to develop a synthetic route for manufacturing of camptothecin derivatives. Avra manufacturing 7-Ethyl-10-hydroxycamptothecin (SN-38)  in dedicated oncology facility which is approved by USFDA. we support  USDMF  and regulatory  fili...